Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cellsJiang Han, Daniel Kim, Kevin V MorrisMethods in Molecular Biology (Clifton, N.J.)|May 15, 2014
Pseudogenes: a novel source of trans-acting antisense RNAsPer Johnsson, Kevin V Morris, Dan GrandérMolecular Therapy. Methods & Clinical Development|April 11, 2022
Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticlesAlicia Davis, Kevin V Morris, Galina ShevchenkoCell Cycle (Georgetown, Tex.)|February 3, 2005
siRNA induced transcriptional gene silencing in mammalian cellsHiroaki Kawasaki, Kazunari Taira, Kevin V MorrisMolecular Therapy. Nucleic Acids|February 20, 2020
Development of a Facile Approach for Generating Chemically Modified CRISPR/Cas9 RNATristan Scott, Citradewi Soemardy, Kevin V MorrisRoyal Society Open Science|November 7, 2015
RNA-directed epigenetic silencing of Periostin inhibits cell motilityNicholas C Lister, Matthew Clemson, Kevin V MorrisImmunology and Cell Biology|March 18, 2015
Long noncoding RNAs: a potent source of regulation in immunity and diseaseAlbert D Yu, Zichen Wang, Kevin V MorrisThe International Journal of Biochemistry & Cell Biology|May 21, 2014
The emerging role of pseudogene expressed non-coding RNAs in cellular functionsJessica N Groen, David Capraro, Kevin V MorrisMolecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2023
Extracellular vesicles: The next generation in gene therapy deliveryRiccardo Cecchin, Zach Troyer, Ken Witwer, et al.EMBO Molecular Medicine|March 14, 2022
RNAi to treat SARS-CoV-2-variant proofing the next generation of therapiesNigel A J McMillan, Kevin V Morris, Adi IdrisPageof 12